MedTrace Logo

Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome

NCT01787591 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-11-22

Study results available
· View outcomes & findings →

Summary

This study is conducted to investigate if vitamin E status in healthy individuals and individuals with metabolic syndrome can be improved by dairy fat. The investigators hypothesize that full-fat dairy will substantially increase the bioavailability of alpha-tocopherol, a form of vitamin E. The results of this study will contribute to the application of dairy fat as a simple and effective strategy for improving vitamin E status, which is partly due to poor vitamin E intake. By completing this study, the investigators anticipate developing new dietary recommendations to achieve adequate vitamin E status through the regular consumption of dairy fat paired with foods containing vitamin E.

Conditions

  • Non-alcoholic Fatty Liver
  • Metabolic Syndrome

Interventions

OTHER

Fat-Free Milk

Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.

OTHER

Low-Fat Milk

Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.

OTHER

Full-Fat Milk

Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.

OTHER

Soy Milk

Soy milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Richard Bruno, PhD, RD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-01-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01787591 on ClinicalTrials.gov